SCHEMBL6679640

SCHEMBL6679640

CCOC(=O)c1c(C)cc(C(=O)O)c(C(=O)O)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.46
NR1H2 P55055 1/20 0.46
NR1H3 Q13133 1/20 0.46
USP2 O75604 2/20 0.44
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
ADORA3 P0DMS8 2/20 0.42
ADORA1 P30542 1/20 0.42
PDE1A P54750 1/20 0.42
PDE1B Q01064 1/20 0.42
PDE3B Q13370 1/20 0.42
PDE1C Q14123 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7379340 0.95 CYP3A4 (0.51) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL11355720 0.90 CYP3A4 (0.47) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL844688 0.89 CYP3A4 (0.47) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL28756311 0.88 CYP3A4 (0.51) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL11355495 0.88 CYP3A4 (0.45) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL11378236 0.84 CYP3A4 (0.47) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL844533 0.82 CYP3A4 (0.49) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL3030086 0.82 CYP3A4 (0.47) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL29927238 0.82 CYP3A4 (0.47) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD
SCHEMBL12552815 0.81 CYP3A4 (0.51) CYP3A4SMN1; SMN2TDP1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100579968-C Quinazolinone derivatives and their use as CB agonists NOVARTIS AG 2010-01-13 CN disclosed
CN-1628104-A Quinazolinone derivatives and their use as CB agonists NOVARTIS AG (CH) 2005-06-15 CN disclosed
EP-1472234-A1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS CB AGONISTS Novartis AG (CH) 2004-11-03 EP disclosed
WO-2003066603-A1 QUINAZOLINONE DERIVATIVES AND THEIR USE AS CB AGONISTS NOVARTIS AG (CH) 2003-08-14 WO disclosed